We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Expert: Watch cGMP Compliance Issues Closely in China
Expert: Watch cGMP Compliance Issues Closely in China
April 4, 2005
U.S. drug manufacturers looking to lower development costs by contracting with Chinese firms for active pharmaceutical ingredients (APIs) need to do so carefully, according to an industry expert, who warned that such partnerships are not always cost-effective.